Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria - Wikidata - awgldk - TriplyDB

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria

http://www.wikidata.org/entity/Q34173643

about

Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adults Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults Detection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications.Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis Assessment of treatment response in tuberculosis Soluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses The Diagnostic Value of Urine Lipoarabinomannan (LAM) Antigen in Childhood Tuberculosis Early morning urine collection to improve urinary lateral flow LAM assay sensitivity in hospitalised patients with HIV-TB co-infection.Point-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in Uganda Update on opportunistic infections in the era of effective antiretroviral therapy Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.Urine lipoarabinomannan point-of-care testing in patients affected by pulmonary nontuberculous mycobacteria--experiences from the Danish Cystic Fibrosis cohort study.Video Q&A: rapid urine LAM test for HIV-associated TB--potential to reduce deaths? An interview with Stephen Lawn Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults.The diagnostic targeting of a carbohydrate virulence factor from M.Tuberculosis.Estimation of D-Arabinose by Gas Chromatography/Mass Spectrometry as Surrogate for Mycobacterial Lipoarabinomannan in Human Urine High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay.Clinical Features and Drug-Resistance Profile of Urinary Tuberculosis in South-Western China: A Cross-sectional Study Challenges facing lipoarabinomannan urine antigen tests for diagnosing HIV-associated tuberculosis.Association of lipoarabinomannan with high density lipoprotein in blood: implications for diagnostics Modification of clearview tuberculosis (TB) enzyme-linked immunosorbent assay for TB patients not infected with HIV.Application of lipoarabinomannan antigen in tuberculosis diagnostics: current evidence.Recent advances in the diagnosis of Mycobacterium tuberculosis.Detection of the tuberculosis antigenic marker mannose-capped lipoarabinomannan in pretreated serum by surface-enhanced Raman scattering.Importance of specimen pretreatment for the low-level detection of mycobacterial lipoarabinomannan in human serum.Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres.Mycobacterium tuberculosis lipoarabinomannan antibodies are associated to rheumatoid arthritis in Sardinian patients.Comparison of the Performance of Urinary Mycobacterium tuberculosis Antigens Cocktail (ESAT6, CFP10, and MPT64) with Culture and Microscopy in Pulmonary Tuberculosis Patients.

P2860

Q24185754-2B087A7B-838C-4137-A7F7-B0C81A484C5B Q24200879-951E59BE-9BCD-4106-B2FC-1E3DB0265F16 Q26765388-3EC39CE6-EFE3-4D88-B626-26AE83783E24 Q28073433-8903910A-5887-4575-BCAC-91B7AADB0D18 Q28384421-06D4DD22-F3DD-441B-8618-8E5F7AF4F7CA Q28534690-660A81E0-C237-42E4-8FAC-AD234EA0BCF8 Q33666322-2349E30A-B936-4D8B-9178-CC8D6402AE82 Q33676996-92AE9CA8-775B-426A-AFF4-029FA6382048 Q33855961-D1E4C703-47EB-428E-B64C-C3E6E9FE78DE Q34085853-FD5D8B48-857A-44DF-ADD3-50F11CE8919A Q34098274-1DBB97E5-C563-4BCC-82DD-DA96A0DD0EDE Q34247819-8738E784-E696-41AC-9122-6D6070D7ED7F Q34660180-C7D9A7CB-DFEC-41EB-8A55-9AF5EC9213E2 Q34798215-85BE39F0-3482-4BBD-8807-B8ED64572E4E Q34978276-AA6BD0EF-E672-4E8D-B5C8-99270C074770 Q35515974-4CAA8CFB-1937-44C3-99AD-72717E4C5F9E Q35608844-2FA0EABF-E227-4586-9C57-50FE4B7470A7 Q35860237-B25D2D97-069F-4820-9502-79095D314AA7 Q36062867-7FE17F4D-CDB3-404C-8CAB-F8CAB12D7F68 Q36993390-EFC4E5F6-0F86-4D4B-B8A9-8E95631FB8D7 Q37249425-03C3E0EF-7E4E-4103-B28C-E66D3D12C967 Q37252503-4320DCC7-A212-444A-9927-05EB90A16F86 Q37469586-4A166439-5F08-4E24-A575-0D351DD32BF9 Q38178810-6B8E02F4-53FB-4689-9BEB-A1DB41366B35 Q38178999-EFBC430A-EE58-430D-8244-6B63E7A2CDA4 Q38376927-97D2571D-7A33-454B-882C-18D604DF66E3 Q40416538-CE115141-B79B-466B-8EAF-5B725F9422AB Q42221349-35554338-509D-4F49-B391-28D67C4D1296 Q43919898-49B08921-F09E-498D-A504-7A190FFB40A6 Q47109648-01F0533F-8F19-46AA-BC2A-601294ABD49F

P2860

Lipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuria

http://www.wikidata.org/entity/Q34173643

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@ast

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@en

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@nl

type

label

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@ast

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@en

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@nl

prefLabel

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@ast

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@en

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@nl

P1433

Q34173643-74680122-6FE2-47C8-85C7-8FA03BD94A94

P1476

Q34173643-DF082774-0952-49A3-A1F7-823B5ED29696

P2093

Q34173643-0A1052D9-F290-41EA-A47F-563C6AAF667A

Q34173643-49A1D042-313B-47C9-AE3B-276825BF04A1

Q34173643-56929D72-BA29-449C-953A-D35A777FB6CA

P2860

Q34173643-04D053EB-4174-4EAD-9ED8-EBADC2990E69

Q34173643-09C085FF-042B-495E-8C00-BB5B67AB7C59

Q34173643-0DDDADDC-5697-47F5-8B42-3E1CE4F522D3

Q34173643-13A3B312-E07C-4D09-8531-F2A78C7C262C

Q34173643-16449A06-FAC7-4372-952D-AD14340FC534

Q34173643-17D22DA0-B090-43D0-AC1D-56B97D3EF014

Q34173643-1B97B236-C53B-41E5-A3EB-135ABCA20F81

Q34173643-2B99D329-4AF7-4149-9DC3-B3F676921F86

Q34173643-33239C7E-F6BF-4605-860B-9B120BAEBCDD

Q34173643-39A56C62-B8AB-4AAA-BE4C-8740FBC3E10C

P2888

Q34173643-EC7E719D-E234-4566-8558-FD9B6F20CDF5

P304

Q34173643-A7A57AF2-149D-4BF9-958E-D252D8E30494

P31

Q34173643-EAA8DAB0-CFAA-4CDB-858E-1957DBDF60EF

P356

Q34173643-999B3853-46BB-4A55-9E33-111AF91FB829

P478

Q34173643-D98E22B1-9A74-43C3-AD2D-AB0D7F65BDC1

P50

Q34173643-32705231-B536-44BF-B102-3B38A0DDBFCA

Q34173643-B18AB77E-BFCA-4708-9931-DC7267C4E647

Q34173643-BCD9CEEE-9132-448F-8E23-AAB0CCBEF53D

Q34173643-E267F3EF-5171-4C8B-8D60-4CC11675DE2A

P577

Q34173643-DAE11316-8158-4489-A9E0-EB36844D2459

P5875

Q34173643-D97F2B44-99A7-4F27-AADC-B20D9D185090

P6179

Q34173643-856C08C7-6745-45E5-96D7-56AA0647D37A

P698

Q34173643-7498634A-3508-4AA4-91C4-BCFC9C1AEAC2

P921

Q34173643-7F4DC5D6-6988-4B6E-BCB3-AA70C3AB4CFF

Q34173643-D33C666D-31F1-4585-9EC1-738014746B56

P932

Q34173643-EF95A895-434E-4DD2-8244-345494B06D8B

P356

1471-2334-12-47

P1433

BMC Infectious Diseases

P1476

Lipoarabinomannan in urine dur ...... en factors and mycobacteriuria

@en

P2093

Barry N Kreiswirth

http://www.w3.org/2001/XMLSchema#string

Kimberly Racow

http://www.w3.org/2001/XMLSchema#string

Monica Vogt

http://www.w3.org/2001/XMLSchema#string

P2860

Xpert® MTB/RIF assay: development, evaluation and implementation of a new rapid molecular diagnostic for tuberculosis and rifampicin resistance

Structural insights into antibody recognition of mycobacterial polysaccharides

Mycobacterium tuberculosis phoP mutant: lipoarabinomannan molecular structure

Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology

Clinical utility of a commercial LAM-ELISA assay for TB diagnosis in HIV-infected patients using urine and sputum samples

Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting.

Development of antigen detection assay for diagnosis of tuberculosis using sputum samples.

Myoglobin: an essential hemoprotein in striated muscle.

Expression of a Mycobacterium tuberculosis arabinomannan antigen in vitro and in vivo

Quantitative analysis of a urine-based assay for detection of lipoarabinomannan in patients with tuberculosis

P2888

1471-2334-12-47

P304

47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2334-12-47

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Linda-Gail Bekker

Keren Middelkoop

P577

2012-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221865581

http://www.w3.org/2001/XMLSchema#string

P6179

1050331074

http://www.w3.org/2001/XMLSchema#string

P698

22369353

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

Lipoarabinomannan

P932

3349560

http://www.w3.org/2001/XMLSchema#string